针灸结合选择性5-羟色胺再摄取抑制剂治疗抑郁症的临床疗效分析 |
投稿时间:2020-06-24 修订日期:2021-04-28 点此下载全文 |
引用本文:李夏珍,宋薇薇,何忠丽.针灸结合选择性5-羟色胺再摄取抑制剂治疗抑郁症的临床疗效分析[J].药学实践杂志,2021,39(4):366~368 |
摘要点击次数: 1185 |
全文下载次数: 775 |
|
|
中文摘要:目的 探究针灸结合选择性5-羟色胺再摄取抑制剂(SSRIs)在治疗抑郁症患者中的临床疗效。方法 选择本院在2019年1月—2020年1月间收治的83例抑郁症患者作为研究对象,对照组抑郁症患者给予SSRIs治疗,联合治疗组在对照组基础上加以针灸治疗,比较两组抑郁症患者的临床疗效,以及治疗前后焦虑(HAMA)和抑郁量表(HAMD)的评分。结果 联合治疗组抑郁症患者临床疗效显著高于对照组,差异有统计学意义(P<0.05);两组抑郁症患者的HAMA与HAMD评分在治疗前均无显著性差异,治疗后两种评分均低于治疗前,差异有统计学意义,联合治疗组抑郁症患者的HAMA与HAMA评分均低于对照组(P<0.05)。结论 针灸结合SSRIs剂治疗抑郁症可以显著改善患者病情,降低患者焦虑、抑郁情绪,对患者治疗具有积极意义。 |
中文关键词:针灸 选择性5-羟色胺再摄取抑制剂 抑郁症 艾灸 临床疗效 |
|
Analysis of the clinical efficacy of acupuncture combined with selective serotonin reuptake inhibitors (SSRIs) in the treatment depression |
|
|
Abstract:Objective To explore the clinical efficacy of acupuncture combined with SSRIs in the treatment of patients with depression.Methods A total of 83 patients with depression admitted to our hospital between January 2019 and January 2020 were selected as the research objects. Patients in the control group were treated with SSRIs, and the combined treatment (observation) group was treated with acupuncture on the basis of the control group. The clinical efficacy, anxiety (HAMD) and depression scale (HAMD) of patients in the two groups were compared.Results After treatment, the clinical efficacy of depression patients in the observation group was significantly higher than that in the control group (P<0.05). HAMA and HAMD scores showed statistical difference between the two groups. HAMA and HAMD scores of patients in the observation group were lower than those in the control group (P<0.05).Conclusion Acupuncture combined with SSRIs in the treatment of depression can significantly improve the patient's condition, reduce the patient's anxiety and depression, and has a positive significance for the treatment of the patients. |
keywords:acupuncture SSRIs depression moxibustion clinical efficacy |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |